中文 | English
Return
Total: 105 , 1/11
Show Home Prev Next End page: GO
MeSH:(Non-alcoholic Fatty Liver Disease/metabolism*)

4.Macrophage heterogeneity role in NAFLD and NASH disease progression.

Tao YANG ; Xiao WANG ; Long Feng JIANG ; Jun LI

Chinese Journal of Hepatology 2023;31(7):770-775

5.Nonalcoholic fatty liver disease and bilirubin: correlation, mechanism, and therapeutic perspectives.

Nian Chen LIU ; Zhong Ping DUAN ; Su Jun ZHENG

Chinese Journal of Hepatology 2023;31(1):101-104

6.Research progress of celastrol on the prevention and treatment of metabolic associated fatty liver disease.

Yun-Chao LIU ; Ying ZHANG ; Shu-Cun QIN ; Jun-Li XUE

Acta Physiologica Sinica 2023;75(5):682-690

8.The Immune Landscape in Nonalcoholic Steatohepatitis.

Sowmya NARAYANAN ; Fionna A SURETTE ; Young S HAHN

Immune Network 2016;16(3):147-158

9.PIK3R3 regulates PPARα expression to stimulate fatty acid β-oxidation and decrease hepatosteatosis

Xi YANG ; Yinjia FU ; Fuqing HU ; Xuelai LUO ; Junbo HU ; Guihua WANG

Experimental & Molecular Medicine 2018;50(1):e431-

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 105 , 1/11 Show Home Prev Next End page: GO